These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10979788)

  • 1. Kaposi's sarcoma.
    Washenik K; Clark-Loeser L; Friedman-Kien A
    N Engl J Med; 2000 Aug; 343(8):581-2; author reply 583-4. PubMed ID: 10979788
    [No Abstract]   [Full Text] [Related]  

  • 2. Alitretinoin (Panretin) gel 0.1%.
    Rhoads J
    J Assoc Nurses AIDS Care; 2001; 12(5):86-91. PubMed ID: 11565242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma: new topical treatment approved.
    James JS
    AIDS Treat News; 1999 Feb; (No 313):1. PubMed ID: 11366235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of AIDS-associated Kaposi's sarcoma with oral tretinoin.
    Bonhomme L; Fredj G; Ecstein E; Maurisson G; Farabos C; Misset JL; Jasmin C
    Am J Hosp Pharm; 1994 Oct; 51(19):2417-9. PubMed ID: 7847408
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid.
    Bonhomme L; Fredj G; Averous S; Szekely AM; Ecstein E; Trumbic B; Meyer P; Lang JM; Misset JL; Jasmin C
    Ann Oncol; 1991 Mar; 2(3):234-5. PubMed ID: 2043496
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of topical 0.1% alitretinoin gel for classic Kaposi sarcoma: first European experience.
    Rongioletti F; Zaccaria E; Viglizzo G
    Br J Dermatol; 2006 Oct; 155(4):856-7. PubMed ID: 16965450
    [No Abstract]   [Full Text] [Related]  

  • 7. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
    Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance given for Panretin gel.
    Oncologist; 1999; 4(2):187. PubMed ID: 10337390
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of isotretinoin in Kaposi's sarcoma.
    Ziegler JL; Volberding PA; Itri LM
    Lancet; 1984 Sep; 2(8403):641. PubMed ID: 6147674
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA news. Food and Drug Administration.
    Res Initiat Treat Action; 1999 Jan; 5(1):20. PubMed ID: 11366229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma. Present concept of clinical course and treatment.
    Davis J
    N Y State J Med; 1968 Aug; 68(15):2067-73. PubMed ID: 4874345
    [No Abstract]   [Full Text] [Related]  

  • 12. Dapsone in the treatment of Kaposi's sarcoma.
    Poulsen A; Hultberg B; Thomsen K; Lange Wantzin G
    Acta Derm Venereol; 1984; 64(6):561-3. PubMed ID: 6084937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus.
    Dittmer DP; Krown SE
    Curr Opin Oncol; 2007 Sep; 19(5):452-7. PubMed ID: 17762570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of AIDS-related Kaposi's sarcoma.
    Di Lorenzo G; Konstantinopoulos PA; Pantanowitz L; Di Trolio R; De Placido S; Dezube BJ
    Lancet Oncol; 2007 Feb; 8(2):167-76. PubMed ID: 17267331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma in an HIV-positive person successfully treated with paclitaxel.
    Dongre A; Montaldo C
    Indian J Dermatol Venereol Leprol; 2009; 75(3):290-2. PubMed ID: 19439884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncytotoxic approaches to the treatment of HIV-associated Kaposi's sarcoma.
    Pluda JM; Parkinson DR; Feigal E; Yarchoan R
    Oncology (Williston Park); 1993 Dec; 7(12):25-33; discussion 33, 37-8. PubMed ID: 8292505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma.
    Krown SE
    J Clin Oncol; 2004 Feb; 22(3):399-402. PubMed ID: 14752065
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
    Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
    AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
    Volkow P; Zinser JW; Correa-Rotter R
    BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
    Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
    N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.